Trademarkia Logo

Canada

C$
THARIMMUNE
FORMALIZED

on 11 Sept 2024

Last Applicant/ Owned by

Tharimmune, Inc.

245 Main Street, Suite 204Chester NJ 07930-2569

US

Serial Number

2349106 filed on 3rd Jun 2024

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

CA

M5A0P6

THARIMMUNE

Trademark usage description

pharmaceutical preparations for use in the treatment of cancers and inflammatory disorders. research and development in the field of cancers and infl Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of cancers and inflammatory disorders.


Classification kind code

12

Class [042]
Research and development in the field of cancers and inflammatory disorders; research and development in the field of pharmaceuticals; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific research; scientific investigations for medical purposes.


Classification kind code

12

Mark Details


Serial Number

2349106

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 135
on 6th Feb 2025
Amendment to Application
Submitted for opposition 48
on 25th Sept 2024
Agent Changed
Submitted for opposition 257
on 12th Sept 2024
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 11th Sept 2024
Formalized
Submitted for opposition 1
on 11th Sept 2024
Created
Submitted for opposition 228
on 3rd Jun 2024
International Registration
Submitted for opposition 30
on 3rd Jun 2024
Filed